Literature DB >> 7252165

A solid phase, direct competition, radioimmunoassay for quantitation of secretory IgA in human serum.

D L Delacroix, J P Vaerman.   

Abstract

A solid phase radioimmunoassay is described for measurement of secretory IgA (sIgA) in human serum. The assay is based on direct competition between sIgA in serum and purified labelled milk sIgA for anti-secretory-component antibodies coated on disposable plastic cups. The assay is relatively rapid, reproducible and of adequate sensitivity. A wide range of sIgA concentrations (5--120 microgram/ml) can be tested with the same dilution of human serum. The arithmetic mean +/- S.D. of the serum sIgA levels of 120 random blood donors (both sexes) was 10.9 +/- 4.6 microgram/ml. Compared to previously published methods and results of quantitation of sIgA in human sera, the present assay is an improvement which should yield interesting data in human hepatic physiopathology.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7252165     DOI: 10.1016/0022-1759(81)90366-5

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  10 in total

1.  Secretory component (SC): preferential binding to heavy (greater than 11S) IgA polymers and IgM in serum, in contrast to predominance of 11S and free SC forms in secretions.

Authors:  D L Delacroix; J P Vaerman
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

2.  Measurement of total, monomeric and polymeric IgA in human faeces by electroimmunodiffusion.

Authors:  D Meillet; D Raichvarg; F Tallet; J Savel; J Yonger; J G Gobert
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

3.  Ontogenic changes in secretory component expression by villous and crypt cells of rat small intestine.

Authors:  J P Buts; D L Delacroix
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

4.  Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection.

Authors:  M Warny; J P Vaerman; V Avesani; M Delmée
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  High serum levels of secretory IgA in liver disease: possible liver origin of the circulating secretory component.

Authors:  D L Delacroix; M Reynaert; S Pauwels; A P Geubel; J P Vaerman
Journal:  Dig Dis Sci       Date:  1982-04       Impact factor: 3.199

6.  Selective transport of polymeric immunoglobulin A in bile. Quantitative relationships of monomeric and polymeric immunoglobulin A, immunoglobulin M, and other proteins in serum, bile, and saliva.

Authors:  D L Delacroix; H J Hodgson; A McPherson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Alterations in polymeric immunoglobulin receptor expression and secretory component levels in bladder carcinoma.

Authors:  M Rossel; C Billerey; H Bittard; P Ksiazek; D Alber; J P Revillard; D A Vuitton
Journal:  Urol Res       Date:  1991

8.  Stimulation of secretory IgA and secretory component of immunoglobulins in small intestine of rats treated with Saccharomyces boulardii.

Authors:  J P Buts; P Bernasconi; J P Vaerman; C Dive
Journal:  Dig Dis Sci       Date:  1990-02       Impact factor: 3.199

9.  Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A.

Authors:  D L Delacroix; K B Elkom; A P Geubel; H F Hodgson; C Dive; J P Vaerman
Journal:  J Clin Invest       Date:  1983-02       Impact factor: 14.808

10.  Higher Levels of Secretory IgA Are Associated with Low Disease Activity Index in Patients with Reactive Arthritis and Undifferentiated Spondyloarthritis.

Authors:  Fabián Salas-Cuestas; Wilson Bautista-Molano; Juan M Bello-Gualtero; Ivonne Arias; Diana Marcela Castillo; Lorena Chila-Moreno; Rafael Valle-Oñate; Daniel Herrera; Consuelo Romero-Sánchez
Journal:  Front Immunol       Date:  2017-04-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.